SINGAPORE (Oct 10): A shift in product offerings towards test & measurement, and medical and life science equipment is opening up new opportunities for Venture Corp, says UOB Kay Hian who is sticking to its “buy” call with a higher target price of $10.30.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

SUBSCRIBE NOW